Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:
Women's Hub News
 

Back to home » News & Views » Treatment News


 

January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007

emailrssprint

August 22, 2008

New Drug Interaction Information With Reyataz

The U.S. Food and Drug Administration (FDA) issued new instructions on potential drug interactions between the protease inhibitor Reyataz (atazanavir) and several other types of medications, including antiretroviral drugs, hormonal contraceptives and stomach acid reducers.

The FDA now recommends not using Reyataz with Viramune (nevirapine), whether or not Reyataz blood levels are boosted with low dose Norvir (ritonavir). This is because Viramune can significantly lower Reyataz blood levels, while Reyataz increases Viramune blood levels.

Another similar drug, efavirenz (found in Sustiva and Atripla), may be combined with Reyataz. However, the recommended daily dose of Reyataz is now 400 mg, and it must be combined with 100 mg of Norvir. The efavirenz dose remains 600 mg once daily at bedtime and on an empty stomach.

The FDA also issued new recommendations about using Reyataz with oral contraceptives, depending on whether or not the Reyataz is being boosted with Norvir. If Reyataz is used without Norvir, women should not take an oral contraceptive that contains more than 30 mcg of ethinyl estradiol. If Reyataz is combined with Norvir, then the birth control pill should contain at least 35 mcg of ethinyl estradiol.

Other types of hormonal contraceptives—such as the contraceptive patch, the contraceptive vaginal ring, injected contraceptives and oral contraceptives containing progestagens other than norethindrone or norgestimate or less than 25 mcg of ethinyl estradiol—have not been studied, and other methods of contraception are recommended.

Finally, another important update includes the use of Reyataz with stomach acid reducers known as H2-receptor antagonists (for instance Pepcid). Some people cannot tolerate Norvir and do not use it with Reyataz. These individuals can now also take an H2-receptor antagonist, provided that the Reyataz is taken at least two hours before or 10 hours after the dose of the H2-receptor antagonist.

NEW! Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

         


[Go to top]


Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Blogs by HIV+ Women
Regan Ann Michelle Annette

Read the blogs
Woman of the Month
Brenda Lee Curry: Aging Gracefully With HIV
Founder, Copasetic Women, New York City

Overheard in the Women's Forum
"I am psychologically suffering from body wasting, mainly hips, face, legs and arms. Does anyone know where I can order something (maybe underwear with foam) to fill the sunken hips, so that pants can start looking normal? I feel pathetic when I look at myself in the mirror in jeans—jeans used to fill up so nicely, now they just hang!"

from Positive Women


Join the forums

Smart + Strong Network
POZ Magazine
POZ Personals
POZ Mentor
POZ ASO Directory
AIDSmeds
Real Health Magazine
TuSalud Magazine
ComboCards
Rx Info Cards
Also visit POZ on...
Facebook

MySpace

YouTube

 
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy